Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2015 1
2016 2
2017 2
2018 6
2019 3
2020 9
2021 3
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
MicroRNAs in breast cancer: Roles, functions, and mechanism of actions.
Abolghasemi M, Tehrani SS, Yousefi T, Karimian A, Mahmoodpoor A, Ghamari A, Jadidi-Niaragh F, Yousefi M, Kafil HS, Bastami M, Edalati M, Eyvazi S, Naghizadeh M, Targhazeh N, Yousefi B, Safa A, Majidinia M, Rameshknia V. Abolghasemi M, et al. Among authors: edalati m. J Cell Physiol. 2020 Jun;235(6):5008-5029. doi: 10.1002/jcp.29396. Epub 2019 Nov 14. J Cell Physiol. 2020. PMID: 31724738 Review.
Critical roles of long noncoding RNAs in breast cancer.
Abolghasemi M, Tehrani SS, Yousefi T, Karimian A, Mahmoodpoor A, Ghamari A, Jadidi-Niaragh F, Yousefi M, Kafil HS, Bastami M, Edalati M, Eyvazi S, Naghizadeh M, Targhazeh N, Mihanfar A, Yousefi B, Safa A, Majidinia M, Rameshknia V. Abolghasemi M, et al. Among authors: edalati m. J Cell Physiol. 2020 Jun;235(6):5059-5071. doi: 10.1002/jcp.29442. Epub 2020 Jan 17. J Cell Physiol. 2020. PMID: 31951025 Review.
PD-L1/PD-1 axis as a potent therapeutic target in breast cancer.
Bastaki S, Irandoust M, Ahmadi A, Hojjat-Farsangi M, Ambrose P, Hallaj S, Edalati M, Ghalamfarsa G, Azizi G, Yousefi M, Chalajour H, Jadidi-Niaragh F. Bastaki S, et al. Among authors: edalati m. Life Sci. 2020 Apr 15;247:117437. doi: 10.1016/j.lfs.2020.117437. Epub 2020 Feb 16. Life Sci. 2020. PMID: 32070710 Review.
PCSK9: A Key Target for the Treatment of Cardiovascular Disease (CVD).
Sobati S, Shakouri A, Edalati M, Mohammadnejad D, Parvan R, Masoumi J, Abdolalizadeh J. Sobati S, et al. Among authors: edalati m. Adv Pharm Bull. 2020 Sep;10(4):502-511. doi: 10.34172/apb.2020.062. Epub 2020 Aug 9. Adv Pharm Bull. 2020. PMID: 33062601 Free PMC article. Review.
EP4 receptor as a novel promising therapeutic target in colon cancer.
Karpisheh V, Joshi N, Zekiy AO, Beyzai B, Hojjat-Farsangi M, Namdar A, Edalati M, Jadidi-Niaragh F. Karpisheh V, et al. Among authors: edalati m. Pathol Res Pract. 2020 Dec;216(12):153247. doi: 10.1016/j.prp.2020.153247. Epub 2020 Oct 19. Pathol Res Pract. 2020. PMID: 33190014 Review.
Promising effect of rapamycin on multiple sclerosis.
Bagherpour B, Salehi M, Jafari R, Bagheri A, Kiani-Esfahani A, Edalati M, Kardi MT, Shaygannejad V. Bagherpour B, et al. Among authors: edalati m. Mult Scler Relat Disord. 2018 Nov;26:40-45. doi: 10.1016/j.msard.2018.08.009. Epub 2018 Aug 10. Mult Scler Relat Disord. 2018. PMID: 30219744 Clinical Trial.
Oxygen-generating microparticles downregulate HIF-1α expression, increase cardiac contractility, and mitigate ischemic injury.
Mandal K, Sangabathuni S, Haghniaz R, Kawakita S, Mecwan M, Nakayama A, Zhang X, Edalati M, Huang W, Lopez Hernandez A, Jucaud V, Dokmeci MR, Khademhosseini A. Mandal K, et al. Among authors: edalati m. Acta Biomater. 2023 Mar 15;159:211-225. doi: 10.1016/j.actbio.2023.01.030. Epub 2023 Jan 18. Acta Biomater. 2023. PMID: 36669549 Free PMC article.
33 results